semaglutide injection information Side Effects: What You Need to Know Semaglutide Injections: Curb Program By

Gastroenterology 152 (4), 840850

Academic press

Personalized plans based on your health history and weight loss goals Physician-supervised care with ongoing monitoring and follow-up Telehealth consultations from anywhere in Pennsylvania no office visit required GLP-1 and GIP prescription medications when clinically appropriate The STEP-1 clinical trial found that semaglutide produced an average weight loss of 12-15% of body weight over 68 weeks in patients with obesity a clinically significant result particularly relevant in Pennsylvania, where approximately 34.4% of adults are affected by obesity according to the CDC

The injection should be given in pregnancy only if indicated, and under healthcare supervision